These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10744426)

  • 21. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Missense mutation in a patient with X-linked dyskeratosis congenita.
    Kraemer DM; Goebeler M
    Haematologica; 2003 Apr; 88(4):ECR11. PubMed ID: 12681984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyskeratosis congenita.
    Handley TP; McCaul JA; Ogden GR
    Oral Oncol; 2006 Apr; 42(4):331-6. PubMed ID: 16140563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new human dyskerin isoform with cytoplasmic localization.
    Angrisani A; Turano M; Paparo L; Di Mauro C; Furia M
    Biochim Biophys Acta; 2011 Dec; 1810(12):1361-8. PubMed ID: 21820037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyskeratosis congenita.
    Gupta V; Kumar A
    Adv Exp Med Biol; 2010; 685():215-9. PubMed ID: 20687509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular diagnosis and therapeutic measures in patients with dyskeratosis congenita].
    Reiger Z; Varga G; Tóth B; Maródi L; Erdos M
    Orv Hetil; 2010 Feb; 151(8):285-92. PubMed ID: 20153999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting dyskeratosis.
    Meier UT
    Nat Genet; 2003 Feb; 33(2):116-7. PubMed ID: 12560816
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
    Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
    Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dyskeratosis congenita caused by a 3' deletion: germline and somatic mosaicism in a female carrier.
    Vulliamy TJ; Knight SW; Heiss NS; Smith OP; Poustka A; Dokal I; Mason PJ
    Blood; 1999 Aug; 94(4):1254-60. PubMed ID: 10438713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
    Vulliamy TJ; Knight SW; Mason PJ; Dokal I
    Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cells, telomerase and dyskeratosis congenita.
    Mason PJ
    Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel missense mutation in the DKC1 gene in a Japanese family with X-linked dyskeratosis congenita.
    Hiramatsu H; Fujii T; Kitoh T; Sawada M; Osaka M; Koami K; Irino T; Miyajima T; Ito M; Sugiyama T; Okuno T
    Pediatr Hematol Oncol; 2002 Sep; 19(6):413-9. PubMed ID: 12186364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DKC1 gene mutation in a Taiwanese kindred with X-linked dyskeratosis congenita.
    Lin JH; Lee JY; Tsao CJ; Chao SC
    Kaohsiung J Med Sci; 2002 Nov; 18(11):573-7. PubMed ID: 12513020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
    Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
    BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel mutation in DKC1 in dyskeratosis congenita.
    Kurnikova M; Shagina I; Khachatryan L; Schagina O; Maschan M; Shagin D
    Pediatr Blood Cancer; 2009 Jan; 52(1):135-7. PubMed ID: 18802941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing.
    Mochizuki Y; He J; Kulkarni S; Bessler M; Mason PJ
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10756-61. PubMed ID: 15240872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice.
    He J; Navarrete S; Jasinski M; Vulliamy T; Dokal I; Bessler M; Mason PJ
    Oncogene; 2002 Oct; 21(50):7740-4. PubMed ID: 12400016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular localization of the Fanconi anemia complementation group A protein.
    Walsh CE; Yountz MR; Simpson DA
    Biochem Biophys Res Commun; 1999 Jun; 259(3):594-9. PubMed ID: 10364463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita.
    Kanegane H; Kasahara Y; Okamura J; Hongo T; Tanaka R; Nomura K; Kojima S; Miyawaki T
    Br J Haematol; 2005 May; 129(3):432-4. PubMed ID: 15842668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.